LIVN

LivaNova PLC

Healthcare · $4.2B market cap

Share price

$75.07

close of Oct 3, 2026

Fair value

$82.43

Sticker Price

Payback Price

$32.97

buy price

Fairly Valued

LIVN is Fairly Valued: at $75.07 it's within 9% of its fair value of $82.43. Its buy price (Payback Price) is $32.97, 56% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow. Sales grew 11% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth264.8% a year✓

Equity per share growth-5.4% a year✗

Sales growth15.3% a year✓

Free cash flow growth7.9% a year✗

Return on invested capital5.3%✗

Follow LIVN

Get notified when it reaches its buy price of $32.97. Free.

Create a free account

Superinvestors

1 of the investors we track holds LIVN. In Q2 2026, 1 sold out. Who we track

David Einhorn

Greenlight Capital · as of Q4 2023

$63.6M

1,229,316 shares

Moves in Q2 2026

Sold out: Lee Ainslie

Insider activity

Since Aug 31, 2026: no open-market purchases and 2 sales worth $319K. Why purchases matter

Sales

Story Brooke

director · 2026-09-04

Sold

$187K

Bianchi Francesco

director · 2026-08-31

Sold

$132K

About LivaNova PLC

LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an…

Medical - Devices